BlackRock
SRTA

BlackRock’s Strata Critical Medical Inc SRTA Stock Holding History

BlackRock’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Buy
4,568,268
+74,651
+2% +$359K ﹤0.01% 3112
2025
Q4 		$21.6M Buy
4,493,617
+173,780
+4% +$841K ﹤0.01% 3061
2025
Q3 		$21.9M Buy
4,319,837
+39,761
+0.9% +$176K ﹤0.01% 3046
2025
Q2 		$17.2M Buy
4,280,076
+253,601
+6% +$825K ﹤0.01% 3122
2025
Q1 		$11M Buy
4,026,475
+49,879
+1% +$179K ﹤0.01% 3271
2024
Q4 		$16.9M Sell
3,976,596
-53,360
-1% -$203K ﹤0.01% 3148
2024
Q3 		$11.8M Buy
4,029,956
+131,473
+3% +$418K ﹤0.01% 3321
2024
Q2 		$13.6M Sell
3,898,483
-124,556
-3% -$415K ﹤0.01% 3206
2024
Q1 		$11.5M Sell
4,023,039
-135,191
-3% -$417K ﹤0.01% 3284
2023
Q4 		$14.7M Buy
4,158,230
+337,840
+9% +$970K ﹤0.01% 3190
2023
Q3 		$9.89M Sell
3,820,390
-175,175
-4% -$615K ﹤0.01% 3341
2023
Q2 		$15.7M Buy
3,995,565
+321,472
+9% +$1.02M ﹤0.01% 3180
2023
Q1 		$12.4M Sell
3,674,093
-27,536
-0.7% -$112K ﹤0.01% 3200
2022
Q4 		$13.3M Sell
3,701,629
-2,175
-0.1% -$9.29K ﹤0.01% 3255
2022
Q3 		$14.9M Sell
3,703,804
-5,604
-0.2% -$28.8K ﹤0.01% 3201
2022
Q2 		$16.5M Buy
3,709,408
+2,841,348
+327% +$20.5M ﹤0.01% 3187
2022
Q1 		$7.37M Sell
868,060
-8,174
-0.9% -$57.4K ﹤0.01% 3747
2021
Q4 		$7.74M Buy
876,234
+116,492
+15% +$1.11M ﹤0.01% 3809
2021
Q3 		$7.9M Buy
759,742
+2,871
+0.4% +$25.1K ﹤0.01% 3781
2021
Q2 		$7.95M Buy
+756,871
New +$7.47M ﹤0.01% 3726

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

BlackRock's SRTA Position: Q1 2026 in Review

BlackRock increased its Strata Critical Medical Inc (SRTA) stake by 1.7% in Q1 2026, buying an estimated $359K and bringing the position to 4,568,268 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

BlackRock first reported a position in SRTA in Q2 2021 and has held it in 20 quarters since. The position peaked at $21.9M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • BlackRock held 4,568,268 shares of Strata Critical Medical Inc worth $19.1M as of Q1 2026.
  • BlackRock bought 74,651 Strata Critical Medical Inc shares in Q1 2026, an estimated $359K.
  • Strata Critical Medical Inc made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3112 holding.
  • BlackRock first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 20 quarters since.
  • BlackRock's Strata Critical Medical Inc position peaked at $21.9M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.